Free Trial

Weaker Ahead Of Payrolls

US TSYS SUMMARY

Tsy futures have pared about half of Thursday's gains amid risk-on headlines overnight, with a heavy slate of data and the final Fed speakers ahead of the pre-FOMC blackout.

  • Positive trial news from a Glaxo-backed vaccine and Reuters reporting that a UK-EU trade deal is "imminent" helped offset some of Thursday's late Pfizer disappointment, boosted equities and weighed on global core FI in European trade.
  • Curve a little steeper: 2-Yr yield is up 0.6bps at 0.1546%, 5-Yr is up 1.3bps at 0.4067%, 10-Yr is up 2.3bps at 0.9294%, and 30-Yr is up 2.5bps at 1.6776%.
  • Mar 10-Yr futures (TY) down 2/32 at 137-19 (L: 137-18 / H: 137-25) though not big volumes (~240k)
  • A busy schedule to end the week, highlighted by the November employment report (alongside trade balance) at 0830ET. MNI dealer median for headline nonfarms is +412.5k (150-735k range), BBG whisper is 500k.
  • 1000ET sees Oct durable goods / factory orders.
  • Fed speakers include Chicago's Evans (0900ET), Gov Bowman (1000ET), Minn's Kashkari (1100ET).
  • NY Fed buys ~$8.825B of 2.25-4.5Y Tsys.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.